Navigation Links
Medtronic Infuse Bone Graft Questioned As Allegations Unfold – Bisnar | Chase Attorneys Offer Free Consultations
Date:7/3/2012

Newport Beach, California (PRWEB) July 03, 2012

According to a public health notification released by the FDA in July of 2008, Infuse bone graft products were used in procedures that the FDA did not grant approval for use with this product.

Senator Max Baucus has personally written a letter to Medtronic stating that "These reports that doctors conducting medical trials while on Medtronic’s payroll may have hidden serious side effects for patients are deeply troubling".

John Bisnar, managing partner of the Bisnar | Chase law firm, alleges that patients who have suffered injuries while utilizing the Infuse Bone Graft devices may be eligible for compensation.

According to Medtronic’s numbers, 500,000 patients have been treated with the Infuse Bone Graft product. The product was designed to assist in the treatment of degenerative disc disease (DDD).

Infuse (recombinant human Bone Morphogenetic Protein-2, rhBMP) is a genetically engineered protein that would normally be found naturally in one’s body. Medtronic claims that if it is used properly, one can stimulate bone formation and avoid additional surgeries during treatment.

The FDA's 2008 public health notification stated that reports had been received associating life-threatening complications with rhBMP when used in the cervical spine. The notification went on to say that “the safety and effectiveness of rhBMP in the cervical spine have not been demonstrated and these products are not approved by the FDA for this use.”

The numbers released by the FDA in their public health notification included 38 reports detailing complications when using Infuse Bone Graft products in cervical spine fusion. Similar complications were reported including swelling of the throat tissue and compression of the airway. Some patients had difficulty speaking, swallowing, and breathing.

According to the Journal Sentinel's June 27th Watchdog Report, a number of complications were associated with use of the Infuse Bone Graft product amongst human trial participants between 2000 and 2009. The report alleges that the Medtronic sponsored trials were conducted by physicians that failed to report the severity of the side effects sustained by the participants.

The doctors associated with the Medtronic Infuse Bone Graft clinical trials stated that "Although not desirable, bone formation in the spinal canal does not appear to have a discernible effect on patient outcomes." "Even though bone formed, no negative outcomes were found," according to the Journal Sentinel.

Reports to the FDA, cited in and leading to their public health notification, produced evidence to the contrary.

Brian Chase, Infuse Bone Graft attorney, has been assisting defective product victims for decades. Mr. Chase has observed first-hand the devastation that product defect victims undergo following the negligence of large corporations.

“Too often, large companies produce products without their consumer’s safety in mind. Product defect victims do not want to believe that businesses may be operated by people who place the priority of their profit margins above their consumer’s level of safety.”

“When manufacturers fail to provide a reasonable level of safety for those who use their products, victims have a right to pursue compensation for their medical expenses, as well as any pain and suffering that may have been caused”, says Brian Chase.

About: Bisnar | Chase, Infuse Bone Graft Lawyers, Orange County, CA

Bisnar | Chase is an Orange County, California based defective product law firm that has developed a reputation as trusted professionals delivering outstanding results. Brian Chase, senior partner, has obtained several multimillion dollar verdicts and settlements on behalf of his product defect clients, including a 24.7 million dollar verdict in August of 2011.

Bisnar | Chase attorneys assist product defect victims throughout the United States.

For matters involving defective products, contact the Bisnar | Chase Infuse Bone Graft lawyers at 800-561-4887 or visit their website at http://www.bestattorney.com/california-class-action-attorneys.html.

Read the full story at http://www.prweb.com/releases/2012/7/prweb9663343.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
2. Miami Children’s Hospital Performs First Nerve Repair Surgery Using Avance® Nerve Graft Technology
3. Donor aortic graft improves reconstruction after partial laryngectomy
4. Fish Oil Doesnt Cut Failure Rate of Hemodialysis Grafts
5. Value of Metformin, Insulin Combo for Type 2 Diabetes Questioned
6. IOC Takes Decisive Action on Ticketing Allegations
7. Prions and cancer: A story unfolding
8. From herd immunity and complacency to group panic: How vaccine scares unfold
9. Fox Chase researchers find no disparities in imaging before breast cancer surgery
10. US Drug Watchdog Now Offers to Help All Woman Who Used Fosamax For Osteoporosis and Then Had an Unexplained a Femur Break Get to the Best Attorneys
11. Mesothelioma Victims Center Now Urges US Navy Veterans Or Individuals With Mesothelioma To Call Them For The Names Of The Best Mesothelioma Attorneys & Treatment Options
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Bellus Medical, a leader in ... a new class of photodynamic cosmetics (PDC). , Allumera® is the first PDC ... signs of aging, and minimize the appearance of pores – all with minimal ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... decision-makers are preparing for how his administration could impact the employee benefits industry. ... what changes are most likely to make it through Congress. His discussion will ...
(Date:4/25/2017)... ... 2017 , ... As pharmaceutical companies are held to increasingly ... innovation in drug formulation and manufacturing. CoreRx offers its clients more than ... support of their development and manufacturing goals. , The company was created ...
(Date:4/25/2017)... ... April 25, 2017 , ... Somnoware, a leading ... patient care management module. Using this new feature, sleep physicians can now predict ... on continuous positive airway pressure (CPAP), oral, or other forms of sleep apnea ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... OAKS, Calif. , April 19, 2017 /PRNewswire/ ... industrial buildings it is developing at Conejo Spectrum ... , to Atara Biotherapeutics, Inc. , ... with severe and life-threatening diseases that have been ... on allogeneic T-cell therapies for cancer, autoimmune and ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... April 18, 2017 Research and Markets has ... report to their offering. ... The global arthroscopy devices market to grow at a CAGR of ... Arthroscopy Devices Market 2017-2021, has been prepared based on an in-depth ... market landscape and its growth prospects over the coming years. The ...
Breaking Medicine Technology: